[Federal Register Volume 87, Number 179 (Friday, September 16, 2022)]
[Notices]
[Pages 56955-56956]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-20127]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60Day-22-0004; Docket No. CDC-2022-0108]


Proposed Data Collection Submitted for Public Comment and 
Recommendations

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice with comment period.

-----------------------------------------------------------------------

SUMMARY: The Centers for Disease Control and Prevention (CDC), as part 
of its continuing effort to reduce public burden and maximize the 
utility of government information, invites the general public and other 
federal agencies the opportunity to comment on a continuing information 
collection, as required by the Paperwork Reduction Act of 1995. This 
notice invites comment on a proposed information collection project 
titled National Disease Surveillance Program--II. Disease Summaries 
information collection. This collection is used to determine the 
prevalence of disease and for planning and evaluating programs for 
prevention and control of infectious diseases.

DATES: CDC must receive written comments on or before November 15, 
2022.

ADDRESSES: You may submit comments, identified by Docket No. CDC-2022-
0108 by either of the following methods:
     Federal eRulemaking Portal: www.regulations.gov Follow the 
instructions for submitting comments.
     Mail: Jeffrey M. Zirger, Information Collection Review 
Office, Centers for Disease Control and Prevention, 1600 Clifton Road 
NE, MS H21-8, Atlanta, Georgia 30329.
    Instructions: All submissions received must include the agency name 
and Docket Number. CDC will post, without change, all relevant comments 
to www.regulations.gov.
    Please note: Submit all comments through the Federal eRulemaking 
portal (www.regulations.gov) or by U.S. mail to the address listed 
above.

FOR FURTHER INFORMATION CONTACT: To request more information on the 
proposed project or to obtain a copy of the information collection plan 
and instruments, contact Jeffrey M. Zirger, Information Collection 
Review Office, Centers for Disease Control and Prevention, 1600 Clifton 
Road NE, MS H21-8, Atlanta, Georgia 30329; Telephone: 404-639-7118; 
Email: [email protected].

SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995 
(PRA) (44 U.S.C. 3501-3520), federal agencies must obtain approval from 
the Office of Management and Budget (OMB) for each collection of 
information they conduct or sponsor. In addition, the PRA also requires 
federal agencies to provide a 60-day notice in the Federal Register 
concerning each proposed collection of information, including each new 
proposed collection, each proposed extension of existing collection of 
information, and each reinstatement of previously approved information 
collection before submitting the collection to the OMB for approval. To 
comply with this requirement, we are publishing this notice of a 
proposed data collection as described below.
    The OMB is particularly interested in comments that will help:
    1. Evaluate whether the proposed collection of information is 
necessary for the proper performance of the functions of the agency, 
including whether the information will have practical utility;
    2. Evaluate the accuracy of the agency's estimate of the burden of 
the proposed collection of information, including the validity of the 
methodology and assumptions used;
    3. Enhance the quality, utility, and clarity of the information to 
be collected;
    4. Minimize the burden of the collection of information on those 
who are to respond, including through the use of appropriate automated, 
electronic, mechanical, or other technological collection techniques or 
other forms of information technology, e.g., permitting electronic 
submissions of responses; and
    5. Assess information collection costs.

Proposed Project

    National Disease Surveillance Program II--Disease Summaries (OMB 
Control No. 0920-0004, Exp. 10/31/2020)--Reinstatement with Change--
National Center for Immunization and Respiratory Diseases (NCIRD), 
Centers for Disease Control and Prevention (CDC).

Background and Brief Description

    CDC requests a three-year approval for the Reinstatement with 
Change of the National Disease Surveillance Program II--Disease 
Summaries information collection. As with the previous approval, these 
data are essential for measuring trends in diseases, evaluating the 
effectiveness of current preventive strategies, and determining the 
need to modify current preventive measures.
    Influenza Virus, Caliciviruses, Respiratory and Enteric Viruses are 
associated with diseases in this surveillance program. Proposed changes 
in this Reinstatements with Change

[[Page 56956]]

include the following: nine influenza forms, Suspect Respiratory Virus 
Patient Form, Middle East Respiratory Syndrome Coronavirus (MERS) 
Patient Under Investigation (PUI) Form, Viral Gastroenteritis Outbreak 
Submission Form, National Respiratory and Enteric Virus Surveillance 
System (NREVSS) Laboratory Assessment, and National Enterovirus 
Surveillance Report. These forms will have minor edits with no burden 
change from last OMB approval.
    In addition to these changes, three new forms have been added 
including an aggregate case count of persons exposed to Highly 
Pathogenic Avian Influenza (HPAI) spreadsheet, Pediatric Hepatitis of 
Unknown Etiology Medical Record Abstraction Form (CRF) and Pediatric 
Hepatitis of Unknown Etiology Medical Record Abstraction short form 
version. The data from the new forms will enable rapid detection and 
characterization of outbreaks of known pathogens, as well as potential 
newly emerging viral pathogens. The NORS Foodborne Disease 
Transmission, and Waterborne Diseases Transmission are discontinued in 
this package, as they have been moved to the OMB-approved package for 
National Outbreak Reporting System (NORS) (OMB Control No. 0920-1304).
    The frequency of response for each form will depend on the disease 
and surveillance need. CDC requests OMB approval for an estimated 
24,320 annual burden hours. There is no additional cost to respondents 
other than the time to participate.

                                                            Estimated Annualized Burden Hours
--------------------------------------------------------------------------------------------------------------------------------------------------------
                                                                                                             Number of    Average burden
               Type of respondent                               Form name                    Number of     responses per   per response    Total burden
                                                                                            respondents     respondent        (in hr)         (in hr)
--------------------------------------------------------------------------------------------------------------------------------------------------------
Epidemiologist.................................  WHO COLLABORATING CENTER FOR INFLUENZA               53              52           10/60             459
                                                  Influenza Virus Surveillance.
Epidemiologist.................................  U.S. WHO Collaborating Laboratories                 113               1           10/60              19
                                                  Influenza Testing Methods Assessment.
Epidemiologist.................................  U.S. Outpatient Influenza-like Illness             1800              52           10/60          15,600
                                                  Surveillance Network (ILINet) Weekly--
                                                  CDC 55.20.
Epidemiologist.................................  US Outpatient Influenza-like Illness               1800               1           15/60             150
                                                  Surveillance Network (ILINet)
                                                  Workfolder 55.20E.
Epidemiologist.................................  Influenza-Associated Pediatric                       57               2           30/60              57
                                                  Mortality--Case Report Form.
Epidemiologist.................................  Human Infection with Novel Influenza A               57               2           30/60              57
                                                  Virus Case Report Form.
Epidemiologist.................................  Human Infection with Novel Influenza A               57               1           90/60              86
                                                  Virus Severe Outcomes.
Epidemiologist.................................  Novel Influenza A Virus Case Screening               57               1           15/60              14
                                                  Form.
Epidemiologist.................................  Antiviral Resistant Influenza Infection              57               3           30/60              86
                                                  Case Report Form.
Epidemiologist.................................  National Respiratory & Enteric Virus                550              52           15/60            7150
                                                  Surveillance System (NREVSS) (55.83A,
                                                  B, D) (electronic).
Epidemiologist.................................  National Enterovirus Surveillance                    20              12           15/60              60
                                                  Report: (CDC 55.9) (electronic).
Epidemiologist.................................  National Adenovirus Type Reporting                   13               4           15/60              13
                                                  System (NATRS).
Epidemiologist.................................  Middle East Respiratory Syndrome (MERS)              57               3           25/60              71
                                                  Patient Under Investigation (PUI)
                                                  Short Form.
Epidemiologist.................................  Viral Gastroenteritis Outbreak                       20               5            5/60               8
                                                  Submission Form.
Epidemiologist.................................  Influenza Virus (Electronic, Year                    57              52            5/60             247
                                                  Round), PHLIP_HL7 messaging Data
                                                  Elements.
Epidemiologist.................................  Influenza virus (electronic, year                     3              52            5/60              13
                                                  round) (PHIN-MS).
Epidemiologist.................................  Suspect Respiratory Virus Patient Form.              10               5           30/60              25
Epidemiologist.................................  Aggregate case counts of persons                     50               9           10/60              75
                                                  exposed to Highly Pathogenic Avian
                                                  Influenza (HPAI).
Epidemiologist.................................  Pediatric Hepatitis of Unknown Etiology              52               4           15/60              52
                                                  Medical Record Abstraction Short Form.
Epidemiologist.................................  Pediatric Hepatitis of Unknown Etiology              52               2           45/60              78
                                                  Medical Record Abstraction Form (CRF).
                                                                                         ---------------------------------------------------------------
    Total......................................  .......................................  ..............  ..............  ..............          24,320
--------------------------------------------------------------------------------------------------------------------------------------------------------


Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific 
Integrity, Office of Science, Centers for Disease Control and 
Prevention.
[FR Doc. 2022-20127 Filed 9-15-22; 8:45 am]
BILLING CODE 4163-18-P